Sort
141,003 grants matching “cytokine”
Engineered metabolite-based nanoparticles for immunomodulation of macrophages to treat obesity
$3,065,252Alireza Hassani Najafabadi · Terasaki Institute For Biomedical Innovation · R01 · FY2025 · DK
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab
$3,063,266Joren C Madsen · Massachusetts General Hospital · U01 · FY2022 · AI
Bone Marrow Grafting for Leukemia and Lymphoma
$3,062,251Stanford University · P01 · FY2004 · CA
Universiity of Rochester Center for Medical Countermeasures against Radiation
$3,055,996Jacqueline Patricia Williams · University Of Rochester · U19 · FY2013 · AI
Universiity of Rochester Center for Medical Countermeasures against Radiation
$3,055,996Jacqueline Patricia Williams · University Of Rochester · U19 · FY2014 · AI
The UCLA Center for Medical Countermeasures Against Radiation
$3,055,696William H. McBride · University Of California Los Angeles · U19 · FY2016 · AI
Nanomedicine Center for Nucleoprotein Machines
$3,054,463Gang Bao · Georgia Institute Of Technology · PN2 · FY2010 · EY
Protective Mechanisms Against Pandemic Respiratory Virus
$3,054,173Ann M Arvin · Stanford University · U19 · FY2007 · AI
Epigenetic changes in synaptic and inflammatory genes involved in the age-dependent development of Alzheimer's disease pathologies andcognitive decline
$3,047,094Thor Stein · Boston University Medical Campus · RF1 · FY2016 · AG
Role of the Non-canonical Inflammasome in SARS-CoV-2-mediated Pathology and Coagulopathy
$3,046,145Amal O Amer · Ohio State University · P01 · FY2024 · AI
The intersection of immunity and cardiovascular diseases
$3,043,800David G Harrison · Vanderbilt University Medical Center · P01 · FY2025 · HL
MECHANISMS AND TREATMENT OF COPD PROGRESSION
$3,041,763Robert A. Wise · Johns Hopkins University · P50 · FY2009 · HL
Controlling and preventing Asthma progression and Severity in Kids (CASK)
$3,041,164Wanda Phipatanakul · Boston Children'S Hospital · U01 · FY2021 · AI
SARS-CoV-2 initiation and acceleration of AD pathology in the setting of endogenous and exogenous risk factors
$3,039,032Ananth V Annapragada · Baylor College Of Medicine · RF1 · FY2025 · NS
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$3,038,595Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Characterizing Innate Immune Dysregulation in Tonsils of Individuals with Down Syndrome
$3,038,439Michael R Verneris · University Of Colorado Denver · R01 · FY2020 · HL
COVID-19: immune response and systems vaccinology
$3,036,975Lothar Hennighausen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Amyloid and inflammation: modulation by apoE, gender, air pollution, and drugs
$3,035,654Caleb E Finch · University Of Southern California · RF1 · FY2015 · AG
Genetic Analysis of T-cell Differentiation
$3,035,016Remy Bosselut · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Non-Human Primate Discovery Team
$3,034,308Norman L Letvin · Duke University · U19 · FY2009 · AI
Endophenotypes of Persistent Post-Concussive Symptoms in Adolescents: CARE4Kids
$3,030,561Christopher C Giza · University Of California Los Angeles · U54 · FY2024 · NS
Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab
$3,029,663Joren C Madsen · Massachusetts General Hospital · U01 · FY2018 · AI
Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders
$3,019,176Carlos Zarate · National Institute Of Mental Health · ZIA · FY2020 · MH
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
$3,015,851Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2016 · AI
Cell Signaling of Host Defense
$3,014,749Michael B Fessler · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES